Molecular Profiling Reveals FH-Deficient Renal Cancer Targets
In a groundbreaking study poised to redefine therapeutic strategies for renal cancers, researchers have unveiled an unprecedented molecular portrait of fumarate hydratase (FH)-deficient renal cell...
















